PROCEDURE     

 

DATE OF PROCEDURE:    

CLINICAL HISTORY:     

OPERATOR: John Doe, MD (Attending)/Jane Doe, MD (Fellow)

MEDICATIONS:     

CONTRAST:     

ACCESS SITE:     

PROCEDURE:

 

The risks, benefits, and alternatives to the procedure and sedation were explained to the  ____ , and written informed consent obtained.

 

The patient was placed in supine position on the angiography table and the     groin were prepped and draped in sterile fashion.  The skin and subcutaneous tissue overlying the     common femoral artery were infiltrated with 2% lidocaine for local anesthetic. Ultrasound of the  ___   groin was performed demonstrating patency of the     Under ultrasound guidance, the  ___   was accessed with a micropuncture needle.   Needle entering the ___  was documented and sent to PACS.  A 0.118 a wire was advanced through the needle into the artery. The needle was exchanged for a 5 French transitional catheter. The inner dilator and the 0.018 wire were removed and a 0.035 Bentson wire was advanced into the artery. The transitional catheter was exchanged for 5 French vascular sheath, attached to a heparinized pressurized bag of saline. A 5 French pigtail catheter was advanced over the wire through the sheath and positioned in the abdominal aorta.   Aortography was performed in     projection using non-ionic contrast.

The catheter was repositioned to the aortic bifurcation, and the pelvis and lower extremities imaged via _____   .

The images were reviewed, and the catheter removed over a wire.  A 5 French dilator was placed, and the patient transferred to the holding area where hemostasis was achieved with compression.  The procedure was well-tolerated, and the patient discharged in stable condition.

 

FINDINGS:

The abdominal aorta shows:    

Left Lower Extremity:

Right Lower Extremity:

 

IMPRESSION: